Cancer Research

Published by: American Association for Cancer Research  

People

  1. Rosen
    Rosen
  2. Solit
    Solit
  3. Berger
    Berger
  4. Schultz
    Schultz
  5. Abdel-Wahab
    Abdel-Wahab
  6. Bajorin
    Bajorin
  7. Hanrahan
    Hanrahan
  8. Iyer
    Iyer
  9. Ladanyi
    Ladanyi
  10. Rosenberg
    Rosenberg

Groups

  1. GSK Faculty (27)
  2. Human Oncology and Pathogenesis Program (27)
  3. Department of Medicine (16)
  4. Solid Tumor Oncology Division (12)
  5. Sloan Kettering Institute Faculty (10)
  6. Sloan Kettering Institute Postdocs (10)
  7. Tow Center for Developmental Oncology (TCDO) (10)
  8. Center for Hematologic Malignancies (9)
  9. Executive Committee, Center for Hematologic Malignancies (9)
  10. Genitourinary Oncology Service (9)
Search Within
  1. "Human Oncology and Pathogenesis Program"
  2. "2014"
Formats
  1. Meeting Abstract (24)
  2. Journal Article (3)
Groups
  1. GSK Faculty (27)
  2. Human Oncology and Pathogenesis Program (27)
  3. Department of Medicine (16)
  4. Solid Tumor Oncology Division (12)
  5. Sloan Kettering Institute Faculty (10)
  6. Sloan Kettering Institute Postdocs (10)

More Groups

People
  1. David Solit (6)
  2. Michael Berger (6)
  3. Neal Rosen (6)
  4. Nikolaus Schultz (5)
  5. Britta Weigelt (4)
  6. Jorge Reis-Filho (4)

More People

Years
  1. 2014 (27)
Publishers
  1. American Association for Cancer Research (27)

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analytical validation of solid tumor fusion gene detection in a comprehensive NGS-based clinical cancer genomic test
    Meeting Abstract

    Yelensky, R.; Donahue, A.; Otto, G.; Nahas, M.; He, J.; Juhn, F.; Downing, S.; Frampton, G. M.; Chmielecki, J.; Ross, J. S.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Oncogenic RAF mutants that signal as functional dimers are resistant to current RAF inhibitors but sensitive to a novel inhibitor of RAF dimer kinase activity
    Meeting Abstract

    Yao, Z.; Torres, M.; Wei, M.; Hanrahan, A.; Abdel-Wahab, O.; Solit, D.; Luo, L. S.; Poulikakos, P.; Rosen, N.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Comprehensive characterization of urothelial bladder cancer: A TCGA Project update
    Meeting Abstract

    Weinstein, J. N.; Kim, J.; Creighton, C. J.; Akbani, R.; Hoadley, K. A.; Kim, W. Y.; Morgan, M. B.; Hinoue, T.; Cherniack, A.; Su, X.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • The clinical behavior of endometrioid and serous endometrial carcinomas is governed by distinct biological processes
    Meeting Abstract

    Weigelt, B.; Lemetre, C.; Ng, C. K. Y.; Piscuoglio, S.; Reis, J. S.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Clinical safety and activity in a phase I trial of AG-221, a first in class, potent inhibitor of the IDH2-mutant protein, in patients with IDH2 mutant positive advanced hematologic malignancies
    Meeting Abstract

    Stein, E.; Tallman, M.; Pollyea, D. A.; Flinn, I. W.; Fathi, A. T.; Stone, R. M.; Levine, R. L.; Agresta, S.; Schenkein, D.; Yang, H.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Application of a multiplexed fluorescence microscopy method (MultiOmyx (TM)) to dissect proteomic biomarkers of (18)F-fluorodeoxy-glucose ((18)FDG) uptake in breast cancer
    Meeting Abstract

    Sood, A.; Miller, A. M.; Ginty, F.; McDonough, E.; Sui, Y. X.; Bordwell, A.; Li, Q.; Kaanumalle, S.; Pang, Z. Y.; Torres, F.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • The antitumor effects of PI3K beta inhibitors in PTEN negative prostate cancer are enhanced by inhibition of reactivated PI3K alpha signaling
    Meeting Abstract

    Schwartz, S.; Carver, B. S.; Wongvipat, J.; Rodrik-Outmezguine, V. ; Destanchina, E.; Trigwell, C.; Barry, S.; Baselga, J.; Chandarlapaty, S.; Scher, H. I.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Targeted capture next generation sequencing of fresh frozen lobular carcinoma in situ and invasive lobular cancer identifies a common repertoire of mutations
    Meeting Abstract

    Sakr, R. A.; Scarpa, J. V. ; Schizas, M.; Giri, D.; De Brot, M.; Towers, R.; Ng, C. K. Y.; Lim, R.; Andrade, V. P.; Weigelt, B.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Acquired resistance to rapamycin and mTOR kinase inhibitors is mediated by non-overlapping mutations in distinct sites in the mTOR protein
    Meeting Abstract

    Rodrik - Outmezguine, V. S.; Yao, Z.; Mukherjee, R.; Cai, L.; Barratt, D.; Ward, R.; Klinowska, T.; Destanchina, E.; Berger, M.; Baselga, J.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Dual lineage inhibition of ETV1 and KIT disrupts the ETV1-KIT feed forward circuit and potentiates imatinib antitumor effect in GIST oncogenesis
    Meeting Abstract

    Ran, L.; Sirota, I.; Cao, Z.; Murphy, D.; Shukla, S.; Rossi, F.; Wongvipat, J.; Tap, W. D.; Besmer, P.; Antonescu, C. R.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save

    • Cancer Research – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association Tor Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 Unknown
    Cancer research 15387445 The Authors the American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer research 15387445 American Association for Cancer Research
    Cancer Research 00085472 Unknown
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer research 15387445 Unknown
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer
    Cancer Research 00085472 The Authors
    Cancer Research 00085472 The Authors the American Association for Cancer Research